Results 141 to 150 of about 65,843 (240)

Cervical Metastasis From Primary Breast Carcinoma: A Case Report and Review of Extragenital Tumors Involving the Uterine Cervix

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Cervical metastases from breast carcinoma should be considered in the differential diagnosis of uterine lesions in patients with prior breast cancer. Re‐biopsy is essential to detect receptor discordance (ER/PR up to 29%) and guide therapy. GCDFP‐15, mammaglobin, and GATA3 confirm mammary origin.
Mario Assenza   +3 more
wiley   +1 more source

Successful simplified genomic profiling of cytology specimens using Aspyre Clinical Test for Lung (Tissue)

open access: yesCancer Cytopathology, Volume 134, Issue 7, July 2026.
Cytology specimens from patients with non–small cell lung cancer were tested using Aspyre Clinical Test for Lung (Tissue) and the results compared to an orthogonal assay. 84/85 samples passed quality control, and all detected variants matched expected results including SNVs from KRAS, SNVs and indels from EGFR, MET exon 14 skipping and gene fusions in ...
Caren Gentile   +17 more
wiley   +1 more source

Docetaxel-Induced Serositis Mimicking Malignant Pleural Effusion. [PDF]

open access: yesClin Case Rep
Anees M   +4 more
europepmc   +1 more source

Molecular profiling of breast cancer pleural effusions using cytology specimens: Impact of sample source and cytological features on next‐generation sequencing performance

open access: yesCancer Cytopathology, Volume 134, Issue 7, July 2026.
ABSTRACT Background Malignant effusions in breast cancer are a minimally invasive source for molecular profiling. Effusion‐derived cytology specimens, cell blocks (CB) and post‐ThinPrep PreservCyt (PTPC) supernatant, are reliable sources for molecular testing but differ in DNA concentration and turnaround time (TAT).
Harpreet Virk   +5 more
wiley   +1 more source

Safety and Efficacy of Single-Stage Synchronous Bilateral VATS Talc Poudrage for Malignant Pleural Effusion. [PDF]

open access: yesCancers (Basel)
Mazzella A   +8 more
europepmc   +1 more source

Role of Evogliptin for Intra‐Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi‐Center, Prospective, Observational Study (REVISE Study)

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 4, July 2026.
ICTI to evogliptin from other DPP‐4 inhibitors significantly improved glycemic control in patients with type 2 diabetes inadequately controlled on metformin‐based therapy. The treatment was well tolerated, supporting ICTI as a pragmatic optimization strategy in routine clinical practice. ABSTRACT Aims While dipeptidyl peptidase‐4 (DPP‐4) inhibitors are
Jie‐Eun Lee   +14 more
wiley   +1 more source

Acute Cardiac Tamponade Following Enfortumab Vedotin Initiation in Metastatic Urothelial Carcinoma: Successful Rescue by Pericardial Fenestration

open access: yesIJU Case Reports, Volume 9, Issue 4, July 2026.
ABSTRACT Introduction Enfortumab vedotin is a Nectin‐4‐directed antibody–drug conjugate approved for metastatic urothelial carcinoma. Cardiac adverse events such as pericardial effusion or tamponade associated with enfortumab vedotin are extremely rare. Case Presentation A 50‐year‐old man with metastatic UC developed chest pain and dyspnea 3 days after
Hiroto Akamatsu   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy